Direkt zum Inhalt

Hoffmann, Thomas K. ; Schirlau, Kerstin ; Sonkoly, Enikö ; Brandau, Sven ; Lang, Stephan ; Pivarcsi, Andor ; Balz, Vera ; Müller, Anja ; Homey, Bernhard ; Boelke, Edwin ; Reichert, Torsten ; Friebe‐Hoffmann, Ulrike ; Greve, Jens ; Schuler, Patrick ; Scheckenbach, Kathrin ; Schipper, Jörg ; Bas, Murat ; Whiteside, Theresa L. ; Bier, Henning

A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration

Hoffmann, Thomas K., Schirlau, Kerstin, Sonkoly, Enikö , Brandau, Sven , Lang, Stephan, Pivarcsi, Andor , Balz, Vera, Müller, Anja, Homey, Bernhard, Boelke, Edwin, Reichert, Torsten, Friebe‐Hoffmann, Ulrike, Greve, Jens, Schuler, Patrick, Scheckenbach, Kathrin, Schipper, Jörg, Bas, Murat, Whiteside, Theresa L. and Bier, Henning (2009) A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration. International Journal of Cancer 124 (11), pp. 2589-2596.

Date of publication of this fulltext: 19 Dec 2024 12:06
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleInternational Journal of Cancer
Publisher:WILEY
Place of Publication:HOBOKEN
Volume:124
Number of Issue or Book Chapter:11
Page Range:pp. 2589-2596
Date2009
InstitutionsMedicine > Lehrstuhl für Mund-, Kiefer- und Gesichtschirurgie
Identification Number
ValueType
10.1002/ijc.24269DOI
KeywordsGROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMAS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECK-CANCER; MONOCLONAL-ANTIBODY; MALIGNANT TRANSFORMATION; CHEMOTACTIC PROTEIN-1; MATUZUMAB EMD-72000; SIGNAL-TRANSDUCTION; SKIN INFLAMMATION; epidermal growth factor receptor; head and neck cancer; spheroids; immune cells; PBMC; chemotaxis
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID67126

Export bibliographical data

Owner only: item control page

nach oben